SHARPE
Reported results
- GAAP net sales were $1,623 million, down from $1,653 million in the prior-year period.
- GAAP net loss attributable to the company was $13 million, or $0.08 per share.
- Non-GAAP adjusted earnings were a loss of $15 million, or $0.09 per share.
- Non-GAAP adjusted EBITDA was $234 million, compared to $329 million in the third quarter of 2025.
- Non-GAAP segment operating profit was $139 million, compared to $235 million in 3Q25.
- GAAP earnings before income taxes were $34 million, down from $58 million in the third quarter of 2025.
Guidance
- For full year 2026, the company expects non-GAAP adjusted EBITDA of $925 million to $950 million.
- For full year 2026, the company expects non-GAAP free cash flow of approximately $(300) million.
- The company expects its net debt leverage ratio will approximate 4.5 to 5.0 times at year end 2026.
- O-I targets approximately $180 million of Fit to Win net benefits in 2026.
- The company estimates related charges of approximately $100 million to $120 million will be recorded in the fourth quarter of 2026 for a proposed permanent closure of a production facility in Europe.
Price and volatility reaction
The stock moved -12.4% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -7.6 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 6.43 | 2026-10-27 |
| Close after release | 5.63 | 2026-10-28 |
| Realised move | -12.4% | close to close |
| 30d ATM IV change | -7.6 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-27 (8-K, Item 2.02). Read the original filing on sec.gov.